These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 32686015)
1. Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents. Lamy M; Pedapati EV; Dominick KL; Wink LK; Erickson CA Paediatr Drugs; 2020 Oct; 22(5):473-483. PubMed ID: 32686015 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders. Lamy M; Erickson CA Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163 [TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents. Stepanova E; Dowling S; Phelps M; Findling RL Dialogues Clin Neurosci; 2017 Dec; 19(4):395-402. PubMed ID: 29398934 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis. Fung LK; Mahajan R; Nozzolillo A; Bernal P; Krasner A; Jo B; Coury D; Whitaker A; Veenstra-Vanderweele J; Hardan AY Pediatrics; 2016 Feb; 137 Suppl 2():S124-35. PubMed ID: 26908468 [TBL] [Abstract][Full Text] [Related]
5. Clinical trials in autism spectrum disorder: evidence, challenges and future directions. Anagnostou E Curr Opin Neurol; 2018 Apr; 31(2):119-125. PubMed ID: 29389748 [TBL] [Abstract][Full Text] [Related]
6. Lurasidone for the treatment of irritability and anger in autism spectrum disorders. McClellan L; Dominick KC; Pedapati EV; Wink LK; Erickson CA Expert Opin Investig Drugs; 2017 Aug; 26(8):985-989. PubMed ID: 28685626 [TBL] [Abstract][Full Text] [Related]
8. Psychopharmacological interventions in autism spectrum disorder. Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879 [TBL] [Abstract][Full Text] [Related]
9. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis. Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602 [TBL] [Abstract][Full Text] [Related]
10. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study. Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215 [TBL] [Abstract][Full Text] [Related]
11. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder. Dominick K; Wink LK; McDougle CJ; Erickson CA J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial. Hendouei F; Sanjari Moghaddam H; Mohammadi MR; Taslimi N; Rezaei F; Akhondzadeh S J Clin Pharm Ther; 2020 Apr; 45(2):324-334. PubMed ID: 31714621 [TBL] [Abstract][Full Text] [Related]
14. Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders. Rizzo R; Pavone P Expert Rev Neurother; 2016 Aug; 16(8):867-74. PubMed ID: 27388494 [TBL] [Abstract][Full Text] [Related]
15. Using antipsychotics for behavioral problems in children. Shafiq S; Pringsheim T Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079 [TBL] [Abstract][Full Text] [Related]
16. Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline. Hellings JA; Arnold LE; Han JC Expert Opin Pharmacother; 2017 Apr; 18(6):581-588. PubMed ID: 28335658 [TBL] [Abstract][Full Text] [Related]
17. Psychopharmacologic management of serious behavioral disturbance in ASD. Stigler KA Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):73-82. PubMed ID: 24231168 [TBL] [Abstract][Full Text] [Related]
18. Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder. Yoon Y; Wink LK; Pedapati EV; Horn PS; Erickson CA J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):822-827. PubMed ID: 27389348 [TBL] [Abstract][Full Text] [Related]
19. Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial? Ayatollahi A; Bagheri S; Ashraf-Ganjouei A; Moradi K; Mohammadi MR; Akhondzadeh S Clin Neuropharmacol; 2020; 43(5):139-145. PubMed ID: 32947424 [TBL] [Abstract][Full Text] [Related]
20. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial. Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]